Business Context and Reporting Period
This Form 8-K filing by Bain Capital Specialty Finance, Inc. (BCSF) reports a material definitive agreement and the creation of a direct financial obligation by a consolidated subsidiary. The report covers events occurring on July 2, 2025 (the "Reset Date"), with the filing date of July 7, 2025. The transaction involves BCC Middle Market CLO 2019-1, Ltd., an indirect, wholly-owned, consolidated subsidiary of BCSF.
Key Financial Metrics and Transaction Details
The filing details the closing of a $430,250,000 term debt securitization refinancing (the "CLO Reset Transaction"). The transaction was 100% funded at closing. The capital structure of the new notes is as follows:
- Total Principal: $430,250,000
- Class A-1-RR Notes: $232,000,000 (AAA(sf), SOFR + 1.45%)
- Class A-2-RR Notes: $16,000,000 (AAA(sf), SOFR + 1.60%)
- Class A-3-RR Notes: $24,000,000 (AA(sf), SOFR + 1.85%)
- Class B-RR Notes: $32,000,000 (A(sf), SOFR + 2.35%)
- Class C-RR Notes: $24,000,000 (BBB(sf), SOFR + 3.35%)
The notes mature on July 15, 2036, with a redemption option available after July 2, 2026. The obligations are non-recourse to BCSF. The filing does not provide specific revenue, profit, cash flow, or margin figures for the reporting period, as this is a transaction-specific report rather than a periodic financial statement.
Material Changes
The primary material change is the refinancing of the existing CLO structure through the issuance of new "Replacement Notes." Key changes include:
- Debt Restructuring: Replacement of prior debt obligations with a new tranche of floating-rate notes tied to SOFR.
- Fee Waiver: BCSF, acting as portfolio manager, has irrevocably waived all portfolio management fees payable under the Amended and Restated Portfolio Management Agreement.
- Collateral Transfer: BCSF will transfer ownership of Collateral Obligations to the CLO Issuer pursuant to the Loan Sale Agreement, shifting the ownership of the underlying loans from the Company to the CLO Issuer.
Outlook, Risks, and Contingencies
Management Commentary and Strategy: The Company continues to act as the retention holder, retaining 100% of the preferred shares (Interests) to satisfy U.S., U.K., and EU securitization regulations. The CLO Issuer intends to use proceeds to purchase loans from the Company over time.
Risks and Contingencies:
- Non-Recourse Nature: The obligations of the CLO Issuers are non-recourse to BCSF, limiting direct liability but exposing the Company to potential reputational or indirect risks associated with the CLO's performance.
- Regulatory Compliance: The transaction is structured to maintain compliance with risk retention regulations.
- Unregistered Securities: The Replacement Notes are not registered under the Securities Act of 1933 and cannot be offered or sold in the U.S. absent registration or an exemption.
Investor Verification Checklist
- Verify the specific terms of the "Amended and Restated Indenture" (Exhibit 10.1) regarding covenants and events of default.
- Confirm the impact of the waived portfolio management fees on BCSF's future revenue streams.
- Review the "Loan Sale Agreement" to understand the timeline and pricing for the transfer of Collateral Obligations from BCSF to the CLO Issuer.
- Assess the credit quality of the diversified portfolio of middle-market commercial loans backing the new notes.
- Monitor the redemption option availability starting July 2, 2026, and its potential impact on the capital structure.